Gene therapy: Is IL2RG oncogenic in T-cell development?

Nature

Volumn 443, Issue 7109, 2006, Pages

  Pike Overzet, Karin ^a   De Ridder, Dick ^b   Weerkamp, Floor ^a   Baert, Miranda R M ^a   Verstegen, Monique M ^a   Brugman, Martijn H ^a   Howe, Steven J ^c   Reinders, Marcel J T ^a   Thrasher, Adrian J ^c   Wagemaker, Gerard ^a   Van Dongen, Jacques J M ^a   Staal, Frank J T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Microelectronics   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 7 RECEPTOR; JANUS KINASE 3; LENTIVIRUS VECTOR; T6 ANTIGEN;

ABSORBANCE; GENE; TUMOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; COMBINED IMMUNODEFICIENCY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; IL2RG GENE; LEUKEMOGENESIS; LMO2 GENE; MUTAGENESIS; NATURAL KILLER CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SCID MOUSE; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENE; X LINKED SEVERE COMBINED IMMUNE DEFICIENCY;

EID: 33748924668     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05218     Document Type: Article

References (7)

1. Woods, N.-B., Bottero, V., Schmidt, M., von Kalle, C. & Verma, I. M. Nature 440, 1123 (2006).
2. Hacein-Bey-Abina, S. et al. N. Engl. J. Med. 348, 255-256 (2003).
3. Marshall, E. Science 299, 320 (2003).
4. Check, E. Nature 433, 561 (2005).
5. Hacein-Bey-Abina, S. et al. Science 302, 415-419 (2003).
6. Dik, W. A. et al. J. Exp. Med. 201, 1715-1723 (2005).
7. Weerkamp, F., Pike-Overzet, K. & Staal, F. J. T. Trends Immunol. 27, 125-131 (2006).